Australia markets closed

Karyopharm Therapeutics Inc. (KPTI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.06000.0000 (0.00%)
At close: 04:00PM EDT
1.0900 +0.03 (+2.83%)
After hours: 06:54PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-143,099
-143,099
-165,291
-124,088
-196,273
Depreciation & amortisation
530
530
621
789
972
Stock-based compensation
21,709
21,709
35,399
29,783
24,407
Change in working capital
31,415
31,415
-19,989
-23,189
1,356
Accounts receivable
20,124
20,124
-5,084
-9,616
-5,019
Inventory
1,181
1,181
-118
-1,462
-2,627
Accounts payable
350
350
1,170
-2,847
3,465
Other working capital
-92,723
-92,723
-149,672
-112,828
-160,379
Other non-cash items
820
820
531
8,029
8,071
Net cash provided by operating activities
-92,723
-92,723
-149,554
-107,116
-160,234
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-118
-5,712
-145
Purchases of investments
-159,151
-159,151
-226,016
-45,228
-274,577
Sales/maturities of investments
167,091
167,091
121,878
192,780
221,037
Net cash used for investing activities
7,940
7,940
-104,256
141,840
-53,685
Cash flows from financing activities
Common stock issued
0
0
189,761
9,903
161,776
Other financing activities
-
-
-
60,000
-
Net cash used provided by (used for) financing activities
1,124
1,124
193,738
73,648
172,083
Net change in cash
-83,693
-83,693
-60,560
108,324
-41,568
Cash at beginning of period
136,885
136,885
197,445
89,121
130,689
Cash at end of period
53,192
53,192
136,885
197,445
89,121
Free cash flow
Operating cash flow
-92,723
-92,723
-149,554
-107,116
-160,234
Capital expenditure
-
-
-118
-5,712
-145
Free cash flow
-92,723
-92,723
-149,672
-112,828
-160,379